Background: Colorectal cancer (CRC) incidence and mortality in those aged 50 years and above have decreased over the last 2 decades. However, there is a rising incidence in CRC among individuals under 50 years of age, termed early-onset colorectal cancer (EOCRC). EOCRC patients are more advanced stage at diagnosis and may suffer more psychosocial, emotional and financial distress.

Objective: Our study examines the epidemiological shifts of CRC in Singapore, a multiethnic country.

Methods: CRCs diagnosed at age 20 and above from 1968 to 2019 were identified from the Singapore Cancer Registry. Patient characteristics included gender, ethnicity and age of diagnosis of CRC. Population information was obtained from the Department of Statistics Singapore. Age specific incidence rates (ASR) and age standardized incidence rates (ASIR) were calculated. The cohort was divided into 3 age groups: 20 - 49, 50 - 64 and ≥65 years. Temporal trends of incidence rates were modelled with Joinpoint Regression. Birth cohort models were fitted using the National Cancer Institute (NCI) age-period-cohort analysis tool. Cancer-specific survival analysis was performed with Cox proportional hazards model.

Results: 53044 CRCs were included, and 6183 (11.7%) adults aged 20 to 49 years were diagnosed with EOCRC. ASR of EOCRC rose from 5 in 1968 to 9 per 100,000 in 1996 at 2.1% annually and rose to 10 per 100,000 in 2019 at 0.64% annually. The ASR for CRC among adults 50 to 64 years rose at 3% annually from 1968 to 1987 and plateaued from 1987 while the ASR for adults aged 65 and above rose at 4.1% from 1968 to 1989 and 1.3% annually from 1989 to 2003 but decreased from 2003 onwards at 1% annually. There is a continued rise in the ASR of EOCRC among males (APC: 1.5%) compared to females (APC: 0.41%) and a significant increase in APC for early-onset rectal cancer at 1.5% yearly. Compared to the 1950 - 1954 birth reference cohort, the 1970 - 1984 birth cohort had a significantly higher incidence rate ratio (IRR) of 1.17 - 1.36 for rectal cancer while there was no significant change for colon cancer in later cohorts. There were differences in CRC trends across the 3 ethnic groups. Malays had a rapid and persistent rise in ASR of CRC across all age groups (APC: 2- 3%) while amongst young Chinese, only the ASR of rectal cancer is increasing (APC: 1.5%). EOCRC patients had better survival compared to patients diagnosed at 65 years and above (HR 0.73, 95% CI 0.67 - 0.79, P <0.001) after adjusting for covariates.

Conclusions: The rise in incidence of rectal cancer among young adults especially among Chinese and Malays in Singapore highlights the need for further research to diagnose CRC earlier and reduce cancer-related morbidity and mortality.

Download full-text PDF

Source
http://dx.doi.org/10.2196/62835DOI Listing

Publication Analysis

Top Keywords

colorectal cancer
12
incidence rates
12
rectal cancer
12
cancer
9
early-onset colorectal
8
aged years
8
eocrc patients
8
age groups
8
birth cohort
8
adults aged
8

Similar Publications

Deficient Mismatch Repair and BRAF Mutations in Metastatic Colorectal Cancer in the South Island of New Zealand.

Asia Pac J Clin Oncol

January 2025

Wellington Blood and Cancer Centre, Health New Zealand/Te Whatu Ora - Capital, Coast and Hutt Valley, Wellington, New Zealand.

Aim: Manatū Hauora, the Ministry of Health of New Zealand (NZ), published minimum standards for molecular testing of colorectal cancers (CRCs) in June 2018. These included mismatch repair (MMR) testing at diagnosis and BRAFV600E mutation analysis on newly diagnosed stage IV CRCs. This study aimed to determine the proportion of patients with CRC in the South Island of NZ with metastatic deficient mismatch repair (dMMR) CRC, the proportion of metastatic CRCs and dMMR CRCs that have a BRAFV600E mutation, and audit testing for BRAF mutations and appropriate referral to genetics services.

View Article and Find Full Text PDF

Objective: This study investigated the association between loss of MSH2/MSH6 versus loss of MLH1/PMS2 expression and overall survival and disease-free survival in patients with localized colorectal cancer.

Background: The risk of developing colorectal cancer varies depending on the expression of mismatch repair proteins. However, it is unknown if the prognosis differs accordingly.

View Article and Find Full Text PDF

Impairment of gut barrier integrity is associated with the pathogenesis of gastrointestinal diseases, including inflammatory bowel disease, colorectal cancer, and coeliac disease. While many aspects of diet have been linked to improved barrier function, (poly)phenols, a broad group of bioactive phytochemicals, are of potential interest. The (poly)phenolic sub-class, flavan-3-ols, have been investigated in some detail owing to their abundance in commonly consumed foods, including grapes, tea, apples, cocoa, berries, and nuts.

View Article and Find Full Text PDF

Background: Low anterior resection (LAR) is the gold standard for curative cancer treatment in the middle and upper rectum. In radically operated patients, the local recurrence rates with total mesorectal excision (TME) after 5 and 10 years was<10%, with 80% in 5 years survival. Anastomotic leakage (AL) affects 4%-20% of patients who underwent LAR.

View Article and Find Full Text PDF

Avenanthramide A potentiates Bim-mediated antineoplastic properties of 5-fluorouracil targeting KDM4C//GSK-3 negative feedback loop in colorectal cancer.

Acta Pharm Sin B

December 2024

Institute of Biotechnology, Key Laboratory of Chemical Biology and Molecular Engineering of National Ministry of Education, Shanxi University, Taiyuan 030006, China.

Chemoresistance to 5-fluorouracil (5-FU) is a significant challenge in treating colorectal cancer (CRC). Novel combined regimens to thwart chemoresistance are therefore urgently needed. Herein, we demonstrated that the combination of Avenanthramide A (AVN A) and 5-FU has significant therapeutic advantages against CRC.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!